Effect of vitamin D supplementation on end treatment response to peginterferon alfa-2b/ribavirin combination in chronic hepatitis c genotype 4

The effect of dual therapy of pegylated interferon and ribavirin on viral load and liver enzymes of hepatitis c patients

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients

Sustained virological response rate to combined antiviral therapy in adult Egyptian patients with histologically mild chronic hepatitis C

Impact of HCV genotype and viral load on the hepatic pathology in Egyptian patients with chronicHCV infection

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C